............  also 2 different companies. Depending on the drugs...

............  also 2 different companies. Depending on the drugs each have very possible to have different outcomes in the generic space. This is a good buying opportunity IMO. Last time it was in the 60s/70s I topped up a lot. It is disappointing to see it come back again of course but this company is well managed and has a great future. Also the directors have plenty of skin in the game. It is a long term hold for me.

..... and this is what the Chair said .........' The rapid turnaround in the second half reflects a rebound of Generic Products, improved performance of Specialty Brands and continued growth of Metrics Contract Services.'

It is just negative sentiment that is affecting the price - nothing else.

Jack